EUVIMEDEUVIMED entdecken
Leserbrief

Efficacy and safety of dupilumab in patients with prurigo nodularis

Xu Li, Jiaojiao Li, Dan Li, Jingxue Guo, Xueying Yang, Change Fan, Huijiao Cai, Caiyan An, Yanfei Li, Junjing Zhang

Archives of Dermatological Research · 2024

DOI: 10.1007/s00403-024-03387-1 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Archives of Dermatological Research, 2024. Verfasst von Xu Li und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Allergy, The First Hospital of Hohhot, Hohhot, 010030, China. Hauptthemen laut MEDLINE: Antibodies, Monoclonal, Humanized, Prurigo. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 5 Literaturangaben. Gefördert von: Health Science and Technology Foundation of Inner Mongolia Autonomous Region.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antibodies, Monoclonal, HumanizedPrurigoHumansFemaleMaleMiddle AgedTreatment OutcomeAdultAged

Stichwörter der Autor:innen

BiologicsDupilumabPrurigo nodularisReal-worldTreatment

Substanzen

dupilumabAntibodies, Monoclonal, Humanized

Autor:innen und Institutionen

  • Department of Allergy, The First Hospital of Hohhot, Hohhot, 010030, China.
  • Department of Dermatology, The First Hospital of Hohhot, Hohhot, 010030, China.
  • Foundational and Translational Medical Research Center, The First Hospital of Hohhot, Hohhot, 010030, China.
  • Department of Allergy, The First Hospital of Hohhot, Hohhot, 010030, China. wishex@sohu.com.
  • Department of Dermatology, The First Hospital of Hohhot, Hohhot, 010030, China. wishex@sohu.com.
  • Foundational and Translational Medical Research Center, Department of Allergy and General Surgery, The First Hospital of Hohhot, No. 150 Nan'erhuan Road, Yuquan District, Hohhot, 010030, Inner Mongolia, China. wishex@so…

Förderung

  • Health Science and Technology Foundation of Inner Mongolia Autonomous Region

Zitieren

APA

Li, X., Li, J., Li, D., Guo, J., Yang, X., Fan, C., Cai, H., An, C., Li, Y., & Zhang, J. (2024). Efficacy and safety of dupilumab in patients with prurigo nodularis. Archives of Dermatological Research. https://doi.org/10.1007/s00403-024-03387-1

Vancouver

Li X, Li J, Li D, Guo J, Yang X, Fan C, et al. Efficacy and safety of dupilumab in patients with prurigo nodularis. Archives of Dermatological Research. 2024. doi:10.1007/s00403-024-03387-1

BibTeX
@article{Li2024,
  author = {Li, Xu and Li, Jiaojiao and Li, Dan and Guo, Jingxue and Yang, Xueying and Fan, Change and Cai, Huijiao and An, Caiyan and Li, Yanfei and Zhang, Junjing},
  title = {Efficacy and safety of dupilumab in patients with prurigo nodularis},
  journal = {Archives of Dermatological Research},
  year = {2024},
  doi = {10.1007/s00403-024-03387-1}
}
Kostenlos starten →